What are the regular dosing guidelines for Regular insulin (human insulin) in a 70-kilogram patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For a 70 kg patient requiring regular insulin, I recommend starting with a weight-based dosing approach of 0.5-0.6 units/kg/day, which equals approximately 35-42 units of total daily insulin, as this approach has been shown to be effective in managing blood glucose levels 1.

Key Considerations

  • The total daily insulin dose should be divided with about 50% as basal insulin (such as NPH, glargine, or detemir) and 50% as mealtime regular insulin split between three meals.
  • Regular insulin should be administered 30 minutes before meals due to its delayed onset of action.
  • Blood glucose monitoring is essential, with checks before meals and at bedtime.
  • The insulin doses should be adjusted based on blood glucose patterns, with increases or decreases of 10-20% every 2-3 days until target glucose levels are achieved.

Adjusting Insulin Doses

  • For correction doses, a common starting point is 1 unit of regular insulin to lower blood glucose by 50 mg/dL (2.8 mmol/L) 2.
  • It is also important to consider the risk of hypoglycemia, particularly when using basal insulin analogs such as glargine or detemir, and to adjust the doses accordingly 3, 4.

Choosing the Right Insulin

  • The choice of basal insulin analog (e.g. glargine, detemir, or degludec) should be based on individual patient needs and characteristics, such as the risk of hypoglycemia and the presence of renal or hepatic impairment 5, 1.
  • Insulin degludec has been shown to be associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.